Actavis plc, of Dublin, and Valeant Pharmaceuticals International Inc., of Laval, Quebec, said the FDA approved the new drug application for Metronidazole 1.3% Vaginal Gel, an antibiotic to treat bacterial vaginosis. Actavis acquired the rights to Metronidazole 1.3% from Valeant in April 2013.